Chemring Sees FY21 Outturn In Line With Board's And Current Analyst Expectations

Chemring Group PLC (CHG.L), a provider of technology products and services, Tuesday said its current trading has progressed as planned despite the challenging environment. The company expects the outturn for the year ending October 31 would be in line with the Board's and current analyst expectations.

Analyst forecasts for adjusted operating profit for the year are in the range of 56.0 million pounds to 59.6 million pounds, with a consensus of 57.5 million pounds.

In its trading update for the period to September 13, the company said its order book as of August 31 was 464 million pounds, compared to 450 million pounds as of April 30.

Order cover for fiscal 2022 is building, with Countermeasures & Energetics having 67 percent order cover of expected revenue and the shorter cycle Sensors & Information sector having 45 percent cover.

The company recorded continued strong performance in the Sensors & Information sector, with order intake up 7 percent compared to the same period last year.

Further, performance across the Countermeasures & Energetics sector is progressing in line with expectations. The Countermeasures & Energetics sector received orders totaling 74 million pounds in the period from May 1 to August 31.

Michael Ord, Chief Executive of Chemring, said, "We have good momentum as we move into FY22. I am confident the focus we have placed on building a high quality, technology-based business will enable us to take further advantage of our increasing opportunities for growth in the coming years and our long-term prospects remain strong."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals.
Follow RTT